Atopic eczema, also known as atopic dermatitis, is a chronic skin condition characterized by inflammation and itching. It is a type of eczema that tends to run in families and is often associated with other allergic conditions like asthma and hay fever.
The company was founded in 1981 with its headquarters in Grand Rapids, Michigan, USA. It is associated with designing and developing medical devices including core biopsy needles, breast biopsy markers. It is also an emerging player in the dermatology sector.
Inrad is involved in the development of various equipment that can aid in the diagnosis of atopic eczema. It is worth noting that this skin disorder can be detected through skin tests and clinical evaluation. The advanced diagnostic instruments offered by this company has been helping medical professionals in their quest to accurately diagnose various skin ailments.
The company was established on October 12th, 2020 with its headquarters in Ahmedabad, Gujarat, India. It is known for offering advanced medical equipment, hospital supplies, and surgical instruments.
Advin develops biopsy instruments that can be used to confirm the diagnosis of atopic eczema or to rule out other skin conditions. The quality and precision of biopsy instruments can be crucial for obtaining accurate tissue samples.
Founded in 1924, this company has its headquarters in Mumbai, India. It is the Indian subsidiary of the global pharma company GSK PLC. It is engaged in the manufacturing, marketing, and distribution of a wide range of pharmaceutical and healthcare products
GlaxoSmithKline is involved in providing medications and solutions to address the symptoms of atopic eczema. It produces drugs relevant to dermatological conditions, such as corticosteroids or other anti-inflammatory medications, may be prescribed by healthcare providers for the treatment of atopic eczema.
Headquartered in New York, US, the company was set up in 1849. It is typically involved in the research, development, manufacturing, and marketing of a wide range of prescription medications, vaccines, and consumer healthcare products.
Pfizer is involved in the development and marketing of medications that are used in the management of atopic eczema. It has also inked collaboration deals with other organizations working in the dermatology and allergy space.
With its headquarters in Paris, France, the company was founded in 1973. It has emerged as one of the largest pharma companies in the world and has a diverse product portfolio.
Sanofi contributes to the treatment of conditions such as atopic eczema by researching and developing drugs, conducting clinical trials, obtaining regulatory approvals, and making these medications available to healthcare professionals and patients.
The landscape of atopic eczema management is being reshaped by the efforts of prominent pharmaceutical companies dedicated to advancing treatment options. Companies such as GlaxoSmithKline, Pfizer, and Sanofi are actively engaged in research, development, and the provision of innovative medications to alleviate the symptoms associated with atopic eczema. Their commitment to understanding the underlying mechanisms of the condition, conducting clinical trials, and bringing effective solutions to market reflects a collective dedication to improving the lives of individuals affected by atopic eczema. As these companies continue to contribute to the evolving field of dermatology, their role remains integral in shaping a future where more targeted, efficient, and patient-centric approaches redefine the standard of care for atopic eczema.
How we can help?